PHOTOCURE PHO NON-REGULATORY PRESS RELEASES

Photocure ASA: Invitation to presentation of first quarter 2026 financial results

30. April 2026 kl. 09:00

Oslo, Norway, 30 April 2026: Photocure ASA (Photocure, PHO: OSE) will announce the first quarter 2026 financial results on Thursday 7 May 2026 at 08:00 CEST and will present a live webcast at 14:00 CEST the same day.

The quarterly report and presentation will be published at 08:00 CEST and will be publicly available at www.photocure.com.

The investor presentation will be streamed live and hosted by Dan Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event. The presentation is scheduled to conclude at 14:45 CEST.

The streaming event is available through https://qcnl.tv/p/xXUD8ZENOu17GeO0kLRJGQ (https://eur01.safelinks.protection.outl ook.com/?url=https%3A%2F%2Fqcnl.tv%2Fp%2FxXUD8ZENOu17GeO0kLRJGQ&data=05%7C02%7CTH %40photocure.no%7C9c98dffa222544e7a72708dea52f1c8b%7C0986794f1d6f488980bd853c0715 d3c1%7C0%7C0%7C639129818977571390%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWU sIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7 C&sdata=U0MqeON103mBP9oE868rFkSjQvXjoG7sg0JiLPiwcSs%3D&reserved=0)

For further information, please contact:

Photocure Erik Dahl CFO Tel: +47 45055000 Email: ed@photocure.com

Priyam Shah Vice President of Investor Relations Tel: +17176815072 Email: priyam.shah@photocure.com

Media enquiries: Geir Bjørlo Corporate Communications (Norway) Tel: +47 91540000 Email: geir.bjorlo@corpcom.no

About Photocure Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com/news

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.